For the best experience on the Abcam website please upgrade to a modern browser such as
Rabbit polyclonal to Kallikrein 5 - Kallikrein loop
This antibody reacts with Kallikrein 5, but does not react with the other Kallikreins (1-7 and 9-15).
Synthetic peptide based on the Kallikrein loop area of human Kallikrein 5.
(Peptide available as
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol
Concentration information loading...
Immunogen affinity purified
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/1000 - 1/5000. Predicted molecular weight: 32 kDa. 1/1000 (when using colorimetric substrates such as BCIP/NBT)- 1/5000 (chemiluminescent substrates). Dilution optimised using Chromogenic detection.
Use at an assay dependent dilution. PubMed: 21163944
May be involved in desquamation.
Expressed in skin, breast, brain and testis. Expressed at the stratum granulosum of palmar skin.
Belongs to the peptidase S1 family. Kallikrein subfamily.
Contains 1 peptidase S1 domain.
Information by UniProt
Kallikrein 5 antibody
Kallikrein L2 antibody
Anti-Kallikrein 5 antibody - Kallikrein loop images
Western blot - Kallikrein 5 antibody - Kallikrein loop (ab28565)
All lanes :
Anti-Kallikrein 5 antibody - Kallikrein loop (ab28565) at 1/1000 dilution
Lane 1 :
Kallikrein 5 at 0.05 µg
Lane 2 :
Kallikrein 5 at 0.01 µg
Lane 3 :
Kallikrein 5 at 0.001 µg
Predicted band size :
Observed band size :
38 kDa (
why is the actual band size different from the predicted?
References for Anti-Kallikrein 5 antibody - Kallikrein loop (ab28565)
This product has been referenced in:
et al. Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J Biol Chem 286:9127-35 (2011).
Read more (PubMed: 21163944) »
et al. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression. Mol Cancer Res 8:145-58 (2010).
Read more (PubMed: 20145038) »
See all 2 Publications
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"